Page last updated: 2024-08-21

indazoles and Pre-Eclampsia

indazoles has been researched along with Pre-Eclampsia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagcivan, I; Karadas, B; Parlak, M; Temiz, TK; Turgut, B; Turgut, NH	1
Brownfoot, FC; Cannon, P; Hannan, NJ; Hastie, R; Kaitu'u-Lino, TJ; Tong, S; Tuohey, L	1

Other Studies

2 other study(ies) available for indazoles and Pre-Eclampsia

Article	Year
Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model. Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:10 Topics: Animals; Aorta, Thoracic; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Female; Fetal Growth Retardation; Guanylate Cyclase; Indazoles; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Pre-Eclampsia; Pregnancy; Proteinuria; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Second Messenger Systems; Suramin; Vasodilation; Vasodilator Agents	2013
YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia. Molecular and cellular endocrinology, 2015, Sep-15, Volume: 413 Topics: Adult; Antigens, CD; Endoglin; Female; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Receptors, Cell Surface; Vascular Endothelial Growth Factor Receptor-1	2015

Article

Year

Investigation of the role of the NO-cGMP pathway on YC-1 and DEA/NO effects on thoracic aorta smooth muscle responses in a rat preeclampsia model.

Canadian journal of physiology and pharmacology, 2013, Volume: 91, Issue:10

Topics: Animals; Aorta, Thoracic; Blood Pressure; Cyclic GMP; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Activators; Enzyme Inhibitors; Female; Fetal Growth Retardation; Guanylate Cyclase; Indazoles; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Pre-Eclampsia; Pregnancy; Proteinuria; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Second Messenger Systems; Suramin; Vasodilation; Vasodilator Agents

2013

YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.

Molecular and cellular endocrinology, 2015, Sep-15, Volume: 413

Topics: Adult; Antigens, CD; Endoglin; Female; Human Umbilical Vein Endothelial Cells; Humans; Indazoles; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Proteins; Receptors, Cell Surface; Vascular Endothelial Growth Factor Receptor-1

2015